Brief: Artivion Announces U.S. FDA Approval Of The Nexus® Aortic Arch System
07/04/2026 12:27
April 7 (Reuters) - Artivion Inc AORT.N: ARTIVION ANNOUNCES U.S. FDA APPROVAL OF THE NEXUS® AORTIC ARCH SYSTEM Source text: ID:nPn6bnNqTa Further company coverage: AORT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artivion
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
Artivion Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Artivion Q2 Revenue USD 125.757 Million Vs. IBES Estimate USD 120 Million
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Artivion Q1 revenue slightly beats, cuts 2026 outlook